Clinical Trial Update: Clemastine Fumarate in the Treatment of Neurodevelopmental Delays in Williams Syndrome [Phase 2]

View source ↗

Summary

This clinical trials update notes the completion of a Phase 2 study evaluating clemastine fumarate for neurodevelopmental delays in children with Williams syndr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurodevelopmental Delay
• Williams Syndrome

Drugs mentioned

• Clemastine Fumarate (clemastine fumarate)

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Williams Syndrome, Child | Phase 2 | Status: COMPLETED